the toxic property of procyanidin B2 towards triple negative breast cancer cells to normal cells offers platform for pre-clinical trial and an insight to the treatment of cancer.
the toxic property of procyanidin B2 towards triple negativebreast cancer cells to normal cells offers platform for pre-clinical trial and an insight to the treatmentof cancer.